Apolipoproteins and coronary artery disease
Related Experiment Videos
Insights
Plasma apolipoprotein levels, particularly apolipoprotein A-I and A-II, are superior markers for identifying coronary artery disease compared to traditional lipid measurements. These findings offer improved diagnostic potential for cardiovascular health.
Area of Science:
- Cardiovascular Medicine
- Biochemistry
- Diagnostic Markers
Background:
- Coronary artery disease (CAD) diagnosis relies on various biomarkers.
- Traditional lipid profiles (cholesterol, triglycerides, HDL) have limitations in identifying significant CAD.
- Apolipoproteins are emerging as potentially more sensitive indicators.
Purpose of the Study:
- To compare the effectiveness of plasma apolipoprotein levels versus traditional lipids in identifying men with significant coronary artery disease.
- To evaluate apolipoprotein A-I, A-II, and B as discriminators for CAD.
- To assess the combined predictive power of age and apolipoprotein levels for CAD classification.
Main Methods:
- Comparative analysis of plasma lipid and apolipoprotein levels in male patients with CAD and healthy controls.
- Measurement of apolipoprotein levels using specific radioimmunoassays.
- Application of linear and quadratic discriminant function analysis for classification accuracy.
Main Results:
- Plasma apolipoprotein A-I, A-II, and B levels demonstrated superior discriminatory ability for CAD compared to cholesterol, triglycerides, and HDL cholesterol.
- CAD presence correlated with lower apolipoprotein A-I/A-II and HDL cholesterol, and higher apolipoprotein B, cholesterol, and triglycerides.
- A model incorporating age and apolipoprotein A-I, A-II, and B achieved over 75% correct classification of CAD status.
Conclusions:
- Plasma apolipoprotein levels, especially A-I and A-II, are more effective markers for identifying significant coronary artery disease than conventional lipid measurements.
- Apolipoprotein profiling offers a promising avenue for enhancing the early detection and risk assessment of cardiovascular disease.
- The integration of apolipoprotein data with clinical factors like age improves diagnostic accuracy for coronary artery disease.
Abstract:
In this study, we compared the relative utility of plasma levels of cholesterol, triglycerides, high-density lipoprotein (HDL) cholesterol, and apolipoproteins in identifying men with angiographically significant coronary artery disease in a combined sample of consecutive male patients undergoing coronary angiography (N = 304) and healthy, normal male control subjects (N = 135). The plasma apolipoprotein levels were measured by using specific radioimmunoassays. We found that plasma levels of apolipoprotein A-I, followed by those of apolipoproteins A-II and B, were better discriminators than plasma cholesterol, triglycerides, or HDL cholesterol levels for identifying those with coronary artery disease. In confirmation of previous findings, the presence of coronary artery disease resulted in lower levels of apolipoproteins A-I and A-II and HDL cholesterol and higher levels of apolipoprotein B, cholesterol, and triglycerides. Linear and quadratic discriminant function analysis demonstrated that by using the age of the patients and apolipoprotein A-I, A-II, and B levels, one could correctly classify patients either as being normal or as having angiographically significant coronary artery disease in more than 75% of the cases. Thus, plasma apolipoprotein levels (especially A-I and A-II) may be considerably better markers for coronary artery disease than traditional lipid determinations.